Share the post "Sunil Healthcare Limited Shareholding Update: An Examination of Financial Performance for FY (Q4-Mar 2023-2024)"
Shareholder Name | Previous Quater Quantity(In Crores) | Current Quater Quantity(In Crores) | Previous Quater Shares(in %) | Current Quater Shares(in %) | Quater to Quater Difference |
---|---|---|---|---|---|
Promoters | 0.75 | 0.75 | 73.53 | 73.53 | 0 |
Public | 0.27 | 0.27 | 26.37 | 26.37 | 0 |
DII | 0.00 | 0.00 | 0.1 | 0.1 | 0 |
FII | 0 | 0 | 0 | 0 | 0 |
Government | 0.00 | 0.00 | 0 | 0 | 0 |
Let’s delve deeper into the statistics of the investors, which could have contributed to the fluctuations in the shareholding pattern.
Shareholder Name | Previous Quarter Quantity (In Crores) | Current Quarter Quantity (In Crores) | Previous Quater Shares (in %) | Current Quater Shares (in %) | Quater-to-Quater Difference (%) |
---|---|---|---|---|---|
Resident Individuals holding nominal share capital up to Rs. 2 lakhs | 0.147 | 0.131 | 14.32 | 12.77 | -1.55 % |
Resident Individuals holding nominal share capital in excess of Rs. 2 lakhs | 0.034 | 0.050 | 3.34 | 4.9 | + 1.56 % |
SHAILESH KUMAR | 0.011 | 0.030 | 1.07 | 2.89 | + 1.82 % |
Non Resident Indians (NRIs) | 0.002 | 0.002 | 0.2 | 0.17 | -0.03 % |
Bodies Corporate | 0.075 | 0.075 | 7.35 | 7.34 | -0.01 % |
Any Other (specify) | 0.012 | 0.012 | 1.16 | 1.17 | + 0.01 % |
HUF | 0.010 | 0.010 | 0.95 | 0.97 | + 0.02 % |
Clearing Members | 0.002 | 0.002 | 0.21 | 0.2 | -0.01 % |
0
3-Year Profit
0
5-Year Profit
0
10-Year Profit
92.0
Current Price
94.4
Market Cap
Upon examining the financial data for BSE code 537253, it becomes clear that the company achieved a notable five-year profit of 0 percents, which impressively increased to 0 percents in the three-year window. This upward trajectory, however, has been overshadowed by the latest trailing twelve-month (TTM) figures, which indicate a concerning loss of -177 percents. This financial loss is further compounded by the fact that the company has not recorded any sales across any of the timeframes under consideration. Such an unusual situation might suggest that the company operates under an unconventional business model, which could potentially carry higher risks. In terms of stock performance, the company’s stock price has seen a decline, falling from 25 percents over the five-year period to just 68 percents in the last year. The ten-year average stock price, which sits at 12 percents, highlights long-term volatility, casting doubt on the company's ability to sustain its market position over time. This warrants further investigation into the factors driving these fluctuations.
With a market capitalization of ₹94.4 crore, the company’s stock is currently trading at ₹92.0, having fluctuated within a range of ₹104 / 49.0 over the years. The stock's P/E ratio of reflects a relatively high valuation compared to its earnings, which could suggest strong future growth expectations or heightened investor demand. The company’s book value is ₹66.5, representing the total value of its assets on a per-share basis, while the dividend yield of 0.00% offers a modest return to shareholders. ROCE, at 2.98%, highlights the company's efficient use of capital in generating profits, while ROE at -2.61% underscores its ability to generate returns for shareholders. The debt-to-equity ratio of 0.97 is very low, indicating conservative financial management and minimal reliance on borrowed funds. Despite this, the company shows a negative net cash flow of ₹-0.51 crore, which could point to cash management challenges or recent heavy investments. The Piotroski score of 2.00 suggests moderate financial strength, while the Graham Number, pegged at ₹, offers a rough estimate of the stock's intrinsic value. The Price-to-Book (P/B) ratio of 1.38 signals that the stock is trading at a premium, which might reflect investor confidence in the company's growth trajectory.